Trial intelligence / Profile preview

NoL Index Correlation with Post-op Pain in VATS

NCT03422783Terminated

Start
Jan 2018
Primary completion
Mar 2024
Countries
1
01

Overview

Open-label, single-arm trial. Primary endpoint: Correlation between NoL index and Hydromorphone consumption at 24 hours. Started Jan 2018; status: terminated.

Beyond the preview

Go deeper on NCT03422783.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03422783.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call